Effects of Spirulina Supplementation on Mental Health in Healthy Adults
1 other identifier
interventional
30
1 country
1
Brief Summary
Spirulina platensis is a form of cyanobacteria, a blue-green algae, and is a superfood most known for being rich in protein, vitamins and minerals, and healthful phytochemicals. Spirulina supports brain health through neuroprotection offered by its antioxidants, anti-inflammatory properties, and hormone regulation. The aim of this study is to supplement healthy adults from a campus community with 3g of spirulina, daily, for 8 weeks to improve mood and mental acuity in comparison to receiving a placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2025
CompletedStudy Start
First participant enrolled
April 15, 2025
CompletedFirst Posted
Study publicly available on registry
April 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedAugust 19, 2025
August 1, 2025
1 year
April 12, 2025
August 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
POMS (profile of mood states questionnaire)
A validated measure consisting of 65 brief phrases, asking how they have personally felt over the last week, including today. The participants were asked to carefully rate their response on a 5-point Likert scale, ranging from 'not at all' to 'extremely'.
conducted at baseline and at week 8 (study's end)
Trail Making Test
The TMT consists of two iterations - versions A and B - and brief samples of each will be provided for the participant to practice prior to the longer, scored version. This is a timed paper and pencil test requiring the participant to connect a series of numbers and/or letters that are randomly arranged.
conducted at baseline and at week 8 (study's end)
Study Arms (2)
spirulina capsules
EXPERIMENTALsix capsules daily (totaling 3 g)
Placebo
PLACEBO COMPARATORPea powder - 6 capsules daily
Interventions
Eligibility Criteria
You may qualify if:
- healthy adults
- ages 18-65
- no underlying chronic disease or acute conditions
- no autoimmune conditions
- do not consume alcohol in excess, smoke, use recreational drugs
- does not follow restrictive diets
- will be recruited from the ASU university campus.
You may not qualify if:
- not have been clinically diagnosed with depression
- not taking antidepressants, anxiety, or stress medications, or any other medications
- drugs, or supplements that could influence mental capacities
- not pregnant or breastfeeding
- not a competitive athlete
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
850 PBC
Phoenix, Arizona, 85004, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Senior Associate Dean
Study Record Dates
First Submitted
April 12, 2025
First Posted
April 20, 2025
Study Start
April 15, 2025
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
August 19, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
We do not plan to publish in ICMJE journals